文献速递眼底病与葡萄膜炎神经眼科

塌陷反应介导蛋白5相关视网膜炎、玻璃体炎和视盘水肿

Collapsin Response-Mediator Protein 5-Associated Retinitis, Vitritis, and Optic Disc Edema.
PubMed 文献 · Ophthalmology · 2019-09-20

回顾性分析76例塌陷反应介导蛋白5(CRMP5)IgG阳性患者,29例(38%)出现神经眼科表现,其中82%为视神经病变且均伴视盘水肿,常合并视网膜炎或葡萄膜炎;62%确诊癌症,72%神经眼科症状早于癌症诊断;接受免疫抑制治疗者50%视力改善。

要点

  • CRMP5 IgG阳性患者中38%出现神经眼科表现,视神经病变多伴视盘水肿。
  • 视网膜炎、玻璃体炎和视盘水肿组合应 prompt CRMP5 IgG检测以争取免疫抑制治疗。
  • 62%患者确诊癌症,72%神经眼科症状出现在癌症诊断之前。

核心结论

  • 在29例CRMP5 IgG阳性伴神经眼科表现的患者中,视神经病变表现为视盘水肿,常合并葡萄膜炎、视网膜炎或两者兼有。
  • 视网膜炎、玻璃体炎和视盘水肿而无视神经强化的组合应促使进行CRMP5 IgG血清学检测,以加速保视力免疫抑制治疗并针对性搜索系统性癌症。

研究设计与样本

  • 回顾性病例系列,纳入2001年至2017年在明尼苏达州罗切斯特梅奥诊所就诊的76例CRMP5自身免疫患者(血清滴度>1:240)。

主要发现

  • 76例中29例(38%)有神经眼科表现,中位年龄67岁(范围33-88岁),20例(69%)为女性。
  • 29例中62%诊断癌症(83%为小细胞癌),72%神经眼科症状出现在癌症诊断之前。
  • 29例中17例(59%)有眼部表现,初诊中位视力20/50(范围20/20-数指),最终中位视力20/40(范围20/20-手动)。
  • 17例中14例(82%)有视神经病变,其中12例合并视网膜炎或葡萄膜炎;3例(18%)仅有视网膜炎或葡萄膜炎无视神经病变。
  • 12例视神经病变且视觉症状起病时有眼底检查记录者均显示视盘水肿;无患者MRI显示视神经强化;29例中12例(41%)有眼球运动功能障碍(中枢性眼震和复视)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Collapsin response-mediator protein 5 (CRMP5) immunoglobulin G (IgG) has been associated with paraneoplastic optic neuritis, vitritis, retinitis, or a combination thereof, but few reports of these findings exist in the literature. We reviewed the neuro-ophthalmic findings and visual outcomes in a large series of CRMP5 IgG-positive patients to characterize further its clinical phenotype and response to treatment. DESIGN: Retrospective case series. PARTICIPANTS: Seventy-six patients with CRMP5 autoimmunity examined at the Mayo Clinic, Rochester, Minnesota. METHODS: Single academic medical center chart review of all CRMP5 IgG-positive (serum titer, >1:240) patients seen between 2001 and 2017. MAIN OUTCOME MEASURES: Neuro-ophthalmic manifestations and outcomes of CRMP5 autoimmunity, coexisting neural autoantibody presence and paraneoplastic associations, and the impact of immunosuppressant therapy. RESULTS: Twenty-nine of 76 patients (38%) demonstrated neuro-ophthalmic manifestations. Of the 29 patients with neuro-ophthalmic findings, the median age was 67 years (range, 33-88 years) and 20 (69%) were women. Cancer was diagnosed in 62% of the patients (small-cell carcinoma in 83%). Neuro-ophthalmic symptoms occurred before the diagnosis of cancer in 72%. Seventeen of 29 patients (59%) showed ocular (i.e., anterior visual pathway or intraocular) manifestations; presenting median visual acuity was 20/50 (range, 20/20-counting fingers) and the final median visual acuity was 20/40 (range, 20/20-hand movements). Fourteen of 17 patients (82%) demonstrated optic neuropathy, with 12 of these patients also showing retinitis or uveitis. Three of 17 patients (18%) showed retinitis or uveitis without optic neuropathy. All 12 patients with optic neuropathy and a documented fundus examination at visual symptom onset demonstrated optic disc edema. No patients showed optic nerve enhancement on magnetic resonance imaging. Twelve of 29 patients (41%) demonstrated ocular motility dysfunction consisting of central nystagmus and diplopia. Among those receiving immunosuppressive therapy, visual function improved in 50%. CONCLUSIONS: In our cohort of 29 CRMP5 IgG-positive patients with neuro-ophthalmic manifestations, optic neuropathy presented with optic disc edema, often associated with uveitis, retinitis, or both. The combination of retinitis, vitritis, and optic disc edema without optic nerve enhancement should prompt serologic testing for CRMP5 IgG to expedite vision-sparing immunosuppressant therapy and a targeted search for a systemic cancer.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Cohen DA, Bhatti MT, Pulido JS, et al. Collapsin Response-Mediator Protein 5-Associated Retinitis, Vitritis, and Optic Disc Edema. Ophthalmology. 2019. PMID: 31676123. doi:10.1016/j.ophtha.2019.09.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。